Hemab Therapeutics
PrivateLast Round
Series C
Oct 27, 2025
Total Funding Raised
$157M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
-
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemab Therapeutics Comparables
Compare Hemab Therapeutics with similar companies based on industry and business-model similarity.
No public comparables are available for Hemab Therapeutics. Request access to learn about comparables coverage.
Request accessHemab Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 27, 2025 |
Hemab Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maj Invest Equity A/S | Series C |
| RA Capital Management | Series C |
| Avoro Ventures | Series C |
| Avoro Capital | Series C |
| Deep Track Capital | Series C |
| HealthCap | Series C |
| Novo Holdings | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
$157M round raised.
Hemab Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hemab Therapeutics's valuation, stock price, and market status.
Is Hemab Therapeutics a public or private company?
Hemab Therapeutics is a private company.
What is the current stock price of Hemab Therapeutics?
Hemab Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Hemab Therapeutics worth (valuation)?
Valuation information for Hemab Therapeutics is not publicly available.
Can I buy Hemab Therapeutics stock?
Hemab Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hemab Therapeutics's last funding round?
Hemab Therapeutics's most recent funding round was Series C on October 27, 2025.
Who are the main investors in Hemab Therapeutics?
Key investors in Hemab Therapeutics include Sofinnova Partners.
Will Hemab Therapeutics IPO soon?
No public IPO plans have been announced for Hemab Therapeutics.
How can I track Hemab Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hemab Therapeutics's secondary market activity and sign up for updates.